acetylglucosamine has been researched along with Cancer of Stomach in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 10 (52.63) | 24.3611 |
| 2020's | 4 (21.05) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, C; Harumiya, S; Kawakubo, M; Matoba, H; Nakayama, J; Sato, Y | 1 |
| Gu, J; Liu, B; Ruan, Y; Song, S; Sun, J; Wang, G; Xu, Z | 1 |
| Asahi, M; Higuchi, K; Moriwaki, K; Takeuchi, T; Ueda, Y | 1 |
| Nakayama, J; Sato, Y; Yamada, S; Yamanoi, K | 1 |
| Cheng, S; Dong, Y; Liu, J; Liu, Q; Mao, Q; Ren, J; Su, L; Ye, X; Zheng, S; Zhou, J; Zhu, N | 1 |
| Asahi, M; Higuchi, K; Inoue, Y; Moriwaki, K; Takeuchi, T; Ueda, Y | 1 |
| Nakayama, J; Yamanoi, K | 1 |
| Roth, J; Taatjes, DJ | 1 |
| Higuchi, K; Kushima, R; Nakayama, J; Sekine, S; Yamanoi, K | 1 |
| Kobayashi, S; Nakayama, J; Okamura, T; Tanaka, E; Yamada, S | 1 |
| Chen, X; Zhang, N | 1 |
| Cheng, S; Liu, J; Liu, Q; Ren, J; Su, L; Ye, X; Zhou, J; Zhu, N | 1 |
| Cai, X; Chu, Y; Fan, D; Fan, X; Horvath, T; Jiang, M; Li, X; Liang, J; Nie, Y; Qiu, Z; Wang, W; Wu, K; Xu, B; Yang, X; Zhang, S; Zhang, X; Zhou, J | 1 |
| Guo, T; Li, Y; Wang, J; Wang, P | 1 |
| Honda, T; Ishii, K; Nakajima, K; Nakayama, J; Ota, H; Sano, K; Zhang, MX | 1 |
| David, L; Ferreira, B; Marcos, NT; Nakayama, J; Reis, CA | 1 |
| Maury, CP | 1 |
| Ikehara, Y; Issiki, S; Itzkowitz, S; Kojima, N; Kono, M; Kudo, T; Kurosawa, N; Morozumi, K; Narimatsu, H; Nishihara, S; Nishimura, SI; Tsuda, T; Tsuji, S | 1 |
| Kakeji, Y; Maehara, Y; Mori, M; Sugimachi, K; Tsujitani, S | 1 |
1 review(s) available for acetylglucosamine and Cancer of Stomach
| Article | Year |
|---|---|
Reduced αGlcNAc glycosylation on gastric gland mucin is a biomarker of malignant potential for gastric cancer, Barrett's adenocarcinoma, and pancreatic cancer.
Topics: Acetylglucosamine; Adenocarcinoma; Animals; Barrett Esophagus; Biomarkers, Tumor; Gastric Mucins; Glycosylation; Humans; Pancreatic Neoplasms; Stomach Neoplasms | 2018 |
18 other study(ies) available for acetylglucosamine and Cancer of Stomach
| Article | Year |
|---|---|
α1,4-Linked N-acetylglucosamine suppresses gastric cancer development by inhibiting Mucin-1-mediated signaling.
Topics: Acetylglucosamine; Adenocarcinoma; Animals; Gastric Mucins; Gastric Mucosa; Humans; Mice; Mucin-1; Mucin-6; Signal Transduction; Stomach Neoplasms | 2022 |
O-GlcNAcylation enhances Reticulon 2 protein stability and its promotive effects on gastric cancer progression.
Topics: Acetylglucosamine; Humans; Membrane Proteins; Phosphorylation; Protein Processing, Post-Translational; Protein Stability; Signal Transduction; Stomach Neoplasms | 2023 |
O-GlcNAcylation-mediated degradation of FBXL2 stabilizes FOXM1 to induce cancer progression.
Topics: Acetylglucosamine; Acylation; Cell Line, Tumor; Cell Proliferation; Disease Progression; F-Box Proteins; Forkhead Box Protein M1; Humans; Protein Stability; Proteolysis; Stomach Neoplasms; Ubiquitination | 2020 |
Diffuse MIST1 expression and decreased α1,4-linked N-acetylglucosamine (αGlcNAc) glycosylation on MUC6 are distinct hallmarks for gastric neoplasms showing oxyntic gland differentiation.
Topics: Acetylglucosamine; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Basic Helix-Loop-Helix Transcription Factors; Biomarkers, Tumor; Cell Differentiation; Female; Gastric Mucosa; Glycosylation; Humans; Male; Middle Aged; Mucin-6; Stomach Neoplasms | 2020 |
GNB2L1 and its O-GlcNAcylation regulates metastasis via modulating epithelial-mesenchymal transition in the chemoresistance of gastric cancer.
Topics: Acetylglucosamine; Cell Line, Tumor; Cell Movement; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Glycosylation; GTP-Binding Proteins; Humans; N-Acetylglucosaminyltransferases; Neoplasm Proteins; Protein Processing, Post-Translational; Receptors for Activated C Kinase; Receptors, Cell Surface; Stomach Neoplasms | 2017 |
Elevated O-GlcNAcylation stabilizes FOXM1 by its reduced degradation through GSK-3β inactivation in a human gastric carcinoma cell line, MKN45 cells.
Topics: Acetylglucosamine; Acylation; beta-N-Acetylhexosaminidases; Cell Line, Tumor; Cell Proliferation; Diabetes Complications; Enzyme Inhibitors; Forkhead Box Protein M1; Glucose; Glycogen Synthase Kinase 3 beta; Humans; Protein Processing, Post-Translational; Protein Stability; Proteolysis; Pyrans; Stomach Neoplasms; Thiazoles; Ubiquitination; Up-Regulation | 2018 |
In focus in HCB.
Topics: Acetylglucosamine; Adipocytes; Animals; Arrhythmias, Cardiac; Biomarkers, Tumor; Gastrointestinal Tract; Genetic Diseases, X-Linked; Gigantism; Heart Defects, Congenital; Humans; Intellectual Disability; Lectins; Phenotype; Polysaccharides; Stomach Neoplasms | 2018 |
Decreased expression of gastric gland mucin-specific glycan α1,4-linked N-acetylglucosamine on its scaffold mucin 6 is associated with malignant potential of pyloric gland adenoma of the stomach.
Topics: Acetylglucosamine; Adenoma; Gastric Mucins; Gastric Mucosa; Humans; Mucin-6; Stomach Neoplasms | 2015 |
Reduced gland mucin-specific O-glycan in gastric atrophy: A possible risk factor for differentiated-type adenocarcinoma of the stomach.
Topics: Acetylglucosamine; Adenocarcinoma; Chronic Disease; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Ki-67 Antigen; Mucin-6; Risk Factors; Stomach Neoplasms | 2015 |
Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro.
Topics: Acetylglucosamine; beta-N-Acetylhexosaminidases; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chromones; Disease Progression; Enzyme Inhibitors; Gene Silencing; Humans; Morpholines; N-Acetylglucosaminyltransferases; Neoplasm Invasiveness; Oncogenes; Phenotype; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Serine; Signal Transduction; Stomach Neoplasms; Up-Regulation | 2016 |
O-GlcNAcylation of the Signaling Scaffold Protein, GNB2L1 Promotes its Degradation and Increases Metastasis of Gastric Tumours.
Topics: Acetylglucosamine; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Glycosylation; GTP-Binding Proteins; Humans; N-Acetylglucosaminyltransferases; Neoplasm Metastasis; Neoplasm Proteins; Protein Binding; Proteolysis; Receptors for Activated C Kinase; Receptors, Cell Surface; RNA, Messenger; Stomach Neoplasms | 2016 |
Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
Topics: Acetylglucosamine; Animals; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase 2; Down-Regulation; Female; Gene Knockdown Techniques; Humans; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; N-Acetylglucosaminyltransferases; Phosphorylation; Protein Processing, Post-Translational; RNA Interference; RNA, Small Interfering; Serine; Stomach Neoplasms; Threonine; Up-Regulation; Xenograft Model Antitumor Assays | 2016 |
Synthesis and cytotoxic activity of the N-acetylglucosamine-bearing triterpenoid saponins.
Topics: Acetylglucosamine; Antineoplastic Agents, Phytogenic; Cell Proliferation; HL-60 Cells; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Molecular Structure; Oleanolic Acid; Saponins; Stomach Neoplasms; Triterpenes; Tumor Cells, Cultured; Ursolic Acid | 2010 |
Expression of gastric gland mucous cell-type mucin in normal and neoplastic human tissues.
Topics: Acetylglucosamine; Adenocarcinoma; Adenoma; Cell Differentiation; Gastric Mucosa; Humans; Immunohistochemistry; Lymphatic Metastasis; Mucin-6; Mucins; N-Acetylglucosaminyltransferases; Neoplasms; Oligosaccharides; Organ Specificity; Sialyl Lewis X Antigen; Stomach Neoplasms | 2003 |
Terminal alpha1,4-linked N-acetylglucosamine in Helicobacter pylori-associated intestinal metaplasia of the human stomach and gastric carcinoma cell lines.
Topics: Acetylglucosamine; Antigens, Tumor-Associated, Carbohydrate; Cell Line, Tumor; Gastric Mucosa; Helicobacter pylori; Humans; Immunohistochemistry; Metaplasia; Mucin-2; Mucins; Stomach; Stomach Neoplasms | 2006 |
Carbohydrate patterns of endoscopic mucosal biopsies in cancer of the stomach and chronic gastritis.
Topics: Acetylgalactosamine; Acetylglucosamine; Adult; Aged; Biopsy; Chronic Disease; Female; Galactose; Gastric Mucosa; Gastritis; Humans; Male; Mannose; Middle Aged; Monosaccharides; Stomach Neoplasms | 1982 |
Cloning and expression of a human gene encoding an N-acetylgalactosamine-alpha2,6-sialyltransferase (ST6GalNAc I): a candidate for synthesis of cancer-associated sialyl-Tn antigens.
Topics: Acetylglucosamine; Adenocarcinoma; alpha-Fetoproteins; Amino Acid Sequence; Animals; Antigens, Tumor-Associated, Carbohydrate; Base Sequence; Carbohydrate Conformation; Cell Transformation, Neoplastic; Chick Embryo; Cloning, Molecular; Colorectal Neoplasms; DNA, Complementary; Gastric Mucosa; Genes; Humans; In Situ Hybridization; Intestinal Mucosa; Metaplasia; Molecular Sequence Data; Neoplasm Proteins; Polymerase Chain Reaction; Precancerous Conditions; Pylorus; Recombinant Fusion Proteins; Sialyltransferases; Species Specificity; Stomach Neoplasms; Substrate Specificity; Transfection | 1999 |
Helix pomatia agglutinin binding activity is a predictor of survival time for patients with gastric carcinoma.
Topics: Acetylgalactosamine; Acetylglucosamine; Female; Humans; Immunoenzyme Techniques; Lectins; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Prognosis; Staining and Labeling; Stomach Neoplasms; Survival Rate | 1991 |